Continuous and precise monitoring of cardiac activity is crucial for the early detection and treatment of cardiovascular diseases. The Viatom ECG Holter TM12 offers an innovative solution for 24-hour ECG monitoring, supported by state-of-the-art artificial intelligence (AI). This device combines ease of use with advanced analytics technology to provide valuable insights into heart health.
The Viatom ECG Holter TM12 is a portable device that continuously records a 12-lead ECG. This comprehensive data acquisition enables a detailed analysis of cardiac activity over a 24-hour period. In contrast to conventional ECG devices, which only provide snapshots, the Holter TM12 records the entire spectrum of cardiac activity in the patient's everyday life.
An outstanding feature of the Viatom ECG Holter TM12 is the integrated AI analysis technology. This technology analyzes the recorded ECG data and automatically detects 17 different types of events, including the most important arrhythmias such as atrial fibrillation, ventricular tachycardia and bradycardia. The AI-supported analysis significantly reduces the time required for evaluation and minimizes the risk of human error. Expert reports confirm the high accuracy and reliability of the AI-supported analysis.
The ease of use of the Viatom ECG Holter TM12 is another major advantage. The device is light and unobtrusive, so it does not interfere with the patient's everyday life. Attaching the electrodes is straightforward and the intuitive user interface allows for easy configuration and monitoring. The recorded data can be transferred wirelessly to a computer or mobile device, where it can be analyzed and visualized with user-friendly software.
Continuous ECG monitoring with the Viatom ECG Holter TM12 offers numerous advantages. It enables the early detection of cardiac arrhythmias that might otherwise go undetected. This is particularly important for patients with an increased risk of cardiovascular disease, such as the elderly, diabetics and patients with high blood pressure. The AI-supported analysis provides doctors with valuable information for the diagnosis and treatment of heart disease.
Conclusion:
The Viatom ECG Holter TM12 is a valuable tool for comprehensive cardiac monitoring. By combining continuous ECG recording, AI-supported analysis and ease of use, it offers an innovative solution for the early detection and treatment of cardiovascular diseases. The technology enables a more precise diagnosis and thus contributes to improved patient care.
